• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Exelixis

NASDAQ:EXEL

$4.61 $0.03 (0.66%)

REAL-TIME: Last trade at

Jump to this page for:

Related Resources

Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 1

5/24/2012 by Seeking Alpha

Prostate Cancer Companies Suffer When They Ignore Urologists

5/22/2012 by Minyanville

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABP

5/18/2012 by 247wallst

Ariad Pharmaceuticals, ArQule, Exelixis, Aveo, Other Cancer Drug Stocks Fall

5/17/2012 by Minyanville

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CY

5/10/2012 by 247wallst

Can Dendreon's New Management Turn Things Around?

5/8/2012 by DailyFinance

MannKind Rents Out a Drug Program

4/30/2012 by DailyFinance

Will the FDA Expand the Label for Amgen's Xgeva?

4/25/2012 by DailyFinance

Whoa! Chelsea Therapeutics and Hercules Offshore Rolled Higher

4/23/2012 by DailyFinance

This Just In: More Upgrades and Downgrades

4/20/2012 by DailyFinance

Stocks Shaking the Investment World

4/19/2012 by DailyFinance

Tomorrow's Monster Stock

4/16/2012 by DailyFinance

4-Star Stocks Poised to Pop: Exelixis

4/13/2012 by DailyFinance

2 Positive Signs for Exelixis

4/3/2012 by DailyFinance

Buy, Sell, or Hold: Exelixis

3/23/2012 by DailyFinance

Early Submission = 60% Pop

3/16/2012 by DailyFinance

This Just In: Upgrades and Downgrades

3/15/2012 by DailyFinance

What's Going on With These Biotech Stocks?

3/8/2012 by DailyFinance

Why Did My Stock Just Die?

3/7/2012 by DailyFinance

This Popular Biotech Could Be in Trouble

2/29/2012 by DailyFinance

Longer Wait, Higher Chance of Success?

2/29/2012 by DailyFinance

5 Superball Stocks

2/21/2012 by DailyFinance

US STOCK FUTURES: HOT STOCKS TO WATCH

2/10/2012 by Smart Money

When Passing Your Clinical Trial Isn't Enough

2/9/2012 by DailyFinance

Can Amgen Convince Docs to Recommend Approval?

2/7/2012 by DailyFinance

FDA Approval Isn't Enough

1/31/2012 by DailyFinance

Make Money in Dynamic Biotech Stocks the Easy Way

1/26/2012 by DailyFinance

The Magic Formula for Biotech

1/13/2012 by DailyFinance

4-Star Stocks Poised to Pop: Exelixis

1/10/2012 by DailyFinance

JPMorgan Confab Kicks Off Biotech 2012

1/5/2012 by Minyanville

5 Reasons to Worry About 2012

1/5/2012 by DailyFinance

Is Exelixis' Growth for Real?

1/4/2012 by DailyFinance

Exelixis: 1 to Watch for 2012

12/30/2011 by DailyFinance

What to Look For From Keryx and Aeterna Zentaris in 2012

12/29/2011 by DailyFinance

Biotech Post-Holiday Regifting

12/28/2011 by DailyFinance

Exelixis 2011: Not What the Doctor Ordered

12/27/2011 by DailyFinance

3 Biotech Stocks That Had a Bad 2011

12/23/2011 by DailyFinance

Exelixis Licenses PI3K-Delta Inhibitor R&D Program To Merck

12/21/2011 by Smart Money

US Stock Futures: HOT STOCKS TO WATCH

12/21/2011 by Smart Money

A Biotech Garage Sale

12/21/2011 by DailyFinance
See More Articles...